ÇOBAN, E. 2020. Comment on "Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy". INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.52, no.9 , 1703.

ÇOBAN, E., (2020). Comment on "Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy". INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.52, no.9, 1703.

ÇOBAN, ERKAN. "Comment on "Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy"," INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.52, no.9, 1703, 2020

ÇOBAN, ERKAN. "Comment on "Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy"." INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.52, no.9, pp.1703, 2020

ÇOBAN, E. (2020) . "Comment on "Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy"." INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.52, no.9, p.1703.

@article{article, author={ERKAN ÇOBAN}, title={Comment on "Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy"}, journal={INTERNATIONAL UROLOGY AND NEPHROLOGY}, year=2020, pages={1703} }